Trials / Completed
CompletedNCT03435627
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect information about safety and effectiveness for long term use of Norditropin®. Participants will attend the medical institution according to usual practice and receive medical care, as agreed with the study doctor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatropin | Participants will be treated with commercially available Norditropin® (somatropin) according to routine clinical practice at the discretion of the treating physician. |
Timeline
- Start date
- 2018-02-26
- Primary completion
- 2022-01-18
- Completion
- 2022-01-18
- First posted
- 2018-02-19
- Last updated
- 2022-11-14
Locations
22 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03435627. Inclusion in this directory is not an endorsement.